Examining immune cell function in breast cancer patients
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
Ohio State University Comprehensive Cancer Center · NCT04022616
This study looks at how certain immune cells work in people with breast cancer to see if it can help find better treatments in the future.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 99 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | Ohio State University Comprehensive Cancer Center (other) |
| Locations | 1 site (Columbus, Ohio) |
| Trial ID | NCT04022616 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on understanding the function of myeloid-derived suppressor cells in patients with breast cancer. It involves collecting specimens from participants to analyze the immune response related to their cancer. The study aims to gather insights that could inform future therapeutic strategies. Participants will be monitored to assess the characteristics and behavior of these immune cells in the context of breast cancer.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older with stage I-III breast malignancy who can provide informed consent.
Not a fit: Patients who are unable to tolerate venipuncture will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance our understanding of immune responses in breast cancer, potentially leading to improved treatment strategies.
How similar studies have performed: While this specific approach is observational, similar studies investigating immune cell functions in cancer have shown promising results in understanding tumor biology.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * Ability to give informed consent * Stage I-III breast malignancy Exclusion Criteria: * Unable to tolerate venipuncture
Where this trial is running
Columbus, Ohio
- Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States (RECRUITING)
Study contacts
- Principal investigator: William Carson, MD — Ohio State Comprehensive Cancer Center
- Study coordinator: Ohio State Comprehensive Cancer Center
- Email: OSUCCCClinicaltrials@osumc.edu
- Phone: 1-800-293-5066
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Breast Cancer